和黄医药(00013.HK)将于本月底美国ASCO年会上披露多项研究数据

阿斯达克财经
May 23, 2025

和黄医药(00013.HK) 公布,其自主研发的化合物赛沃替尼(savolitinib)、HMPL-306 (ranosidenib)、呋喹替尼(fruquintinib)和索凡替尼(surufatinib)的数项研究的最新及更新后的数据,将于5月30日至6月3日在美国芝加哥召开的2025年美国临床肿瘤学会(ASCO)年会上公布。SACHI中国III期研究的结果将以最新突破性口头报告的形式公布,该...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10